Navigator Case Management for People Leaving Jail
Resource from the RWHAP Best Practices Compilation updated on 01/19/2024
Resource from the RWHAP Best Practices Compilation updated on 01/19/2024
Resource updated 04/16/2024
Resource from the RWHAP Best Practices Compilation updated on 03/23/2024
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
RWHAP Technical Assistance Provider updated on 07/09/2024
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource from the RWHAP Best Practices Compilation updated on 11/14/2023
Resource updated 04/17/2024
Resource (Conference Presentation) updated 09/14/2023
HRSA's HIV/AIDS Bureau's Division of Community HIV/AIDS Programs (DCHAP) held a session for recipients.
Resource (Conference Presentation) updated 09/14/2023
By cross matching registries of HIV and other sexually transmitted infections, this study found 27.1% of male syphilis cases were coinfected with HIV and 31.8% of those coinfected were not virally suppressed. This suggests ongoing sexual risk behaviors and the potential for HIV transmission among male syphilis cases.
Resource (Conference Presentation) updated 09/14/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
Overview of barriers and facilitators to Pap test utilization for women with HIV who receive RWHAP Part D services. Using the Socio-Ecological Model, the individual, interpersonal, community, and healthcare system level barriers and facilitators are explored.
Resource (Conference Presentation) updated 09/14/2023
Utilization of a peer support specialist to increase routine bacterial sexually transmitted infection screening, testing, and treatment in an urban clinic and related patient care outcomes.
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023
Screening protocols developed to identify more opportunities for testing at multiple sites and in asymptomatic individuals among persons at risk individuals with HIV to prevent and treat STIs.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023